Nicht-thermische endovenöse Therapie: die Acrylatverklebung der Stammvarikose

Zusammenfassung

Die endovenöse Behandlung der Varikose hat sich als effektive Alternative zur chirurgischen Behandlung mittels Stripping und hoher Ligatur etabliert - allen voran die thermischen Verfahren Laser- und Radiofrequenzablation. Wenngleich diese Methoden sehr schonend und patientenfreundlich sind, so gehen auch mit ihnen Risiken und Nebenwirkungen einher. Gegenüber der offen-chirurgischen Therapie ist das Risiko einer Schädigung peripherer und motorischer Nerven zwar reduziert, besteht aber dennoch im Rahmen der Hitzewirkung und der Tumeszenzanästhesie.

Nicht-thermische Verfahren, die ohne Tumeszenz durchzuführen sind, drängen auf den Markt. Sie besitzen ein deutlich geringeres Risiko für Nervenläsionen bei hoher Effektivität. Die Arbeit analysiert den aktuellen Kenntnis-stand zur jüngsten Entwicklung, der Verklebung der inkompetenten Stammvenen mittels Cyanoacrylat.

Schlüsselwörter

Cyanoacrylat - Acrylatverklebung - Stammvarikose - endovenöse Varizentherapie

• References

• 1 Babcock WW. A new operation fort he exstirpation of varicose veins of the leg. N Y Med J 1907; 86: 153-156.
• 2 van Eekeren RR. et al. Update of endovenous treatment modalities for insufficient saphenous veins. Sem Vasc Surg 2014; 7: 117-135.
• 3 Rasmussen L. et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3-year follow-up. J Vasc Surg: Ven Lymph Dis 2013; 1 (Suppl. 04) 349-356.
• 4 Gloviczki P. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53 (Suppl. 05) 2S-48S.
• 5 http://guidance.nice.org.uk/CG168 published 07/2013, download 2016–02–07.
• 6 Hirsch T. Varicose vein therapy and nerve lesions. Vasa 2017; 46 (Suppl. 02) 96-100.
• 7 Almeida JI. et al. Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovasc Surg 2011; 45: 631-635.
• 8 2017 Buyer´s guide.. Endovascular Today Europe. 2017 5 (1).
• 9 Kolluri R, Gibson K, Cher D. et al. Roll-in phase analysis of clinical study of cyanoacrylate closure for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord 2016; Oct 4 (Suppl. 04) 407-415.
• 10 Quinn JC, Mittal N, Baisre A. et al. Vascular inflammation with eosinophils after the use of n-butyl cyanoacrylate liquid embolic system. J Neurointerv Surg 2011; 3 (Suppl. 01) 21-24.
• 11 Wang YM, Cheng LF, Li N. Histopathological study of vascular changes after intra-arterial and intravenous injection of N-butyl-2-cyanoacrylate. Chin J Dig Dis 2006; 7 (Suppl. 03) 175-179.
• 12 Johnson GW, Smith GW. Effect Of Methyl Cyanoacrylate On The Central Nervous System. Nerve Anastomosis Surg Forum 1963; 14: 414-416.
• 13 Trott AT. Cyanoacrylate tissue adhesives. An advance in wound care. JAMA 1997; 277 (Suppl. 19) 1559-1560.
• 14 Brothers MFI. et al. n-Butyl 2-cyanoacrylate-substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. Am J Neuroradiol 1989; 10 (Suppl. 04) 777-786.
• 15 Sohn JJ. et al. Comparison of 2-Ethyl-Cyanoacry-late and 2-Butyl-Cyanoacrylate for Use on the Calvaria of CD1 Mice. J Am Assoc Lab Anim Sci 2016; 55 (Suppl. 02) 199-203.
• 16 Toriumi DM. et al. Histotoxicity of cyanoacry-late tissue adhesives. A comparative study. Arch Otolaryngol Head Neck Surg 1990; 116: 546-550.
• 17 Nitsch A, Pabyk A, Honig JF. et al. Cellular, histomorphologic, and clinical characteristics of a new octyl-2-cyanoacrylate skin adhesive. Aesthetic Plast Surg 2005; 29 (Suppl. 01) 53-58.
• 18 Vinters HV. et al. The histotoxicity of cyanoacrylates. Neuroradiology 1985; 27 (Suppl. 04) 279-291.
• 19 Leggat PA, Smith DR, Kedjarune U. Surgical applications of cyanoacrylate adhesives: a review of toxicity. ANZ J Surg 2007; 77 (Suppl. 04) 209-213.
• 20 Leggat PA. et al. Toxicity of cyanoacrylate adhesives and their occupational impacts for dental staff. Ind Health 2004; 42 (Suppl. 02) 207-211.
• 21 Studer M, Pouget-Jasson C, Waton J. et al. A. How testing allergic contact dermatitis from octylcyanoacrylate tissue glue (Dermabond®). Revue francaise d’allergologie 2010; 50: 75-76.
• 22 Bowen C. et al. Allergic contact dermatitis to 2-octyl cyanoacrylate. Cutis 2014; 94 (Suppl. 04) 183-186.
• 23 Calnan CD. Cyanoacrylate dermatitis. Contact Dermatitis 1979; 5: 165-167.
• 24 Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular 2016 May 20. pii: 1708538116651014.
• 25 Almeida JI, Javier JJ, Mackay EG. et al. Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology 2015; 30 (Suppl. 06) 397-404.
• 26 Proebstle T, Alm J, Dimitri S. et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg: Venous and Lym Dis 2015; 3 (Suppl. 01) 2-7.
• 27 Morrison N. et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg 2015; 61 (Suppl. 04) 985-994.
• 28 Çalık ES, Arslan Ü, Ayaz F. et al. N-butyl cyanoacrylate in the treatment of venous insufficiencythe effect of embolisation with ablative polymerisation. Vasa 2016; 45 (Suppl. 03) 241-246.
• 29 Zierau UT. 101420-Tage-Ergebnisse an 795 behandelten Stammvenen. Vasomed 2015; 27: 124-127.
• 30 Zierau UT. Venenverklebung versus Radiofrequenztherapie bei Varikosis. Vasomed 2016; 5: 212-216.
• 31 Almeida JI, Javier JJ, Mackay E. et al. First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord 2013; 1 (Suppl. 02) 174-180.
• 32 Almeida JI. et al. Three-Year Follow-Up of First Human Use of Cyanoacrylate Adhesive for Treat-.